HCAL
COLL icon

HURRICANE CAPITAL ADVISORS LLC’s Collegium Pharmaceutical COLL Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,691
Closed -$122K – 806
2026
Q1 		$122K Buy
+3,691
New +$156K 0.04% 342

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's COLL Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 3,691 shares — an estimated $122K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in COLL in Q1 2026 and held it in 1 quarter. The position peaked at $122K in Q1 2026. 281 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 3,691 Collegium Pharmaceutical shares in Q2 2026, an estimated $122K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Collegium Pharmaceutical in Q1 2026 and held it in 1 quarter.
  • HURRICANE CAPITAL ADVISORS LLC's Collegium Pharmaceutical position peaked at $122K in Q1 2026.
  • 281 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.